Home   |   R & D   |   Products   |   Custom Service   |   Ordering   |   Resources   |   Ventures   |   Careers   |   Contact Us   


Immunoassay/ELISA Kits


Immunoglobulins


ELISpot Kits


Matched Antibody Pairs


Monoclonal Antibodies


Polyclonal Antibodies


Miscellaneous


Custom Service


Product Catalog


Science Bulletin Board


Distributor Resources


Articles


In The News


   

Search this Site

     

PIPELINE OF THERAPEUTIC PRODUCTS

   

Product Design and Development Preclinical Trial Pre-IND Phase I Clinical Trial Phase II Clinical Trial Phase III Clinical Trial Phase IV Clinical Trial

ABCream

(Psoriasis treatment)

             
             
             
             
             

ABCream

(Eczema treatment)

             
             
             
         
         

Cardiolin

(Heart Disease Treatment)

             
             
             

ABCan

(Lung Cancer treatment)

             
             
             

ABPro

(Prostate Cancer treatment)

             
             
             

ALZheilin

(Alzheimer's Disease treatment)

             
             
             

Anti-chemokine(Inflmamatory treatment)

             
     
     

 

The test has been scheduled in China

The test/phase has been completed in China

The test has been scheduled in North America

The test/phase has been completed in North America

 

ABCREAM: A topical therapeutic cream for psoriasis and eczema, containing anti-human IL-8 monoclonal antibodies.
   
CARDIOLIN (Platelet Aggregation Inhibitor): Consists of a pair of monoclonal antibodies specific for fibrinogen receptor IIb and IIIa on human platelets, inhibiting platelet aggregation.  The antibodies showed potential therapeutic effects on cardiovascular disease.
    
ABCAN: Anti-angiogenic chemokine (IL-8) MAb for the treatment of lung cancer.
    
ABPRO: Anti-PSMA MAb for the targeting, diagnosis and treatment of prostate cancer.
    
ALZHEILIN: Anti-FPRL1 MAb for the treatment of Alzheimer's Disease (AD)
    
The nTSH Kit: For the in vitro determination of Neonatal Thyroid Stimulating Hormone for the prevention of Thyroid-related conditions.  Licensed by Health Canada as a Class III Medical Device License.
    
LPDL Project: For the treatment and prevention of TG-related CVD including hypertriglyceridemia and atherosclerosis.  Patents issued and research underway.
    

Copyright @ 2010 Yes Biotech Laboratories Ltd. in association with Anogen.  All rights reserved.

|Affiliates | Privacy Policy | Security | Site Map |